Literature DB >> 31256059

Neuronal microtubules and proteins linked to Parkinson's disease: a relevant interaction?

Alessandra M Calogero1, Samanta Mazzetti1,2, Gianni Pezzoli2,3, Graziella Cappelletti1,4.   

Abstract

Neuronal microtubules are key determinants of cell morphology, differentiation, migration and polarity, and contribute to intracellular trafficking along axons and dendrites. Microtubules are strictly regulated and alterations in their dynamics can lead to catastrophic effects in the neuron. Indeed, the importance of the microtubule cytoskeleton in many human diseases is emerging. Remarkably, a growing body of evidence indicates that microtubule defects could be linked to Parkinson's disease pathogenesis. Only a few of the causes of the progressive neuronal loss underlying this disorder have been identified. They include gene mutations and toxin exposure, but the trigger leading to neurodegeneration is still unknown. In this scenario, the evidence showing that mutated proteins in Parkinson's disease are involved in the regulation of the microtubule cytoskeleton is intriguing. Here, we focus on α-Synuclein, Parkin and Leucine-rich repeat kinase 2 (LRRK2), the three main proteins linked to the familial forms of the disease. The aim is to dissect their interaction with tubulin and microtubules in both physiological and pathological conditions, in which these proteins are overexpressed, mutated or absent. We highlight the relevance of such an interaction and suggest that these proteins could trigger neurodegeneration via defective regulation of the microtubule cytoskeleton.

Entities:  

Keywords:  LRRK2; Parkin; Parkinson’s disease; microtubules; tubulin; α-Synuclein

Mesh:

Substances:

Year:  2019        PMID: 31256059     DOI: 10.1515/hsz-2019-0142

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  8 in total

Review 1.  The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity.

Authors:  Manqing Wu; Hang Su; Min Zhao
Journal:  Neurotox Res       Date:  2021-02-08       Impact factor: 3.911

2.  Functional Cooperation of α-Synuclein and Tau Is Essential for Proper Corticogenesis.

Authors:  Shengming Wang; Yu Fu; Takaki Miyata; Sakiko Matsumoto; Tomoyasu Shinoda; Kyoko Itoh; Akihiro Harada; Shinji Hirotsune; Mingyue Jin
Journal:  J Neurosci       Date:  2022-07-29       Impact factor: 6.709

3.  Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.

Authors:  Stylianos Ravanidis; Anastasia Bougea; Dimitra Karampatsi; Nikolaos Papagiannakis; Matina Maniati; Leonidas Stefanis; Epaminondas Doxakis
Journal:  Mov Disord       Date:  2021-01-12       Impact factor: 10.338

4.  Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson's Patient-Derived Neuronal Cells.

Authors:  Lukas Seebauer; Yanni Schneider; Alice Drobny; Sonja Plötz; Tomas Koudelka; Andreas Tholey; Iryna Prots; Beate Winner; Friederike Zunke; Jürgen Winkler; Wei Xiang
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

5.  Prognostic significance of SNCA and its methylation in bladder cancer.

Authors:  Zhengcun Wu; Chengxing Xia; Chao Zhang; Delin Yang; Kaili Ma
Journal:  BMC Cancer       Date:  2022-03-26       Impact factor: 4.430

6.  Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation.

Authors:  Katharina Pieger; Verena Schmitt; Carina Gauer; Nadja Gießl; Iryna Prots; Beate Winner; Jürgen Winkler; Johann Helmut Brandstätter; Wei Xiang
Journal:  Biomolecules       Date:  2022-08-12

Review 7.  Biochemical Pathways of Cellular Mechanosensing/Mechanotransduction and Their Role in Neurodegenerative Diseases Pathogenesis.

Authors:  Ilaria Tortorella; Chiara Argentati; Carla Emiliani; Francesco Morena; Sabata Martino
Journal:  Cells       Date:  2022-10-01       Impact factor: 7.666

8.  Parkinson mice show functional and molecular changes in the gut long before motoric disease onset.

Authors:  Manuela Gries; Anne Christmann; Steven Schulte; Maximilian Weyland; Stephanie Rommel; Monika Martin; Marko Baller; Ralph Röth; Stefanie Schmitteckert; Marcus Unger; Yang Liu; Frederik Sommer; Timo Mühlhaus; Michael Schroda; Jean-Pierre Timmermans; Isabel Pintelon; Gudrun A Rappold; Markus Britschgi; Hilal Lashuel; Michael D Menger; Matthias W Laschke; Beate Niesler; Karl-Herbert Schäfer
Journal:  Mol Neurodegener       Date:  2021-06-02       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.